OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
August 23, 2016
Valeant Pharmaceuticals International, Inc. (Laval, Quebec, Canada) announced that Paul S. Herendeen has been appointed Executive Vice President, Finance and will take over the role of Chief Financial Officer from Robert L. Rosiello, effective immediately. Mr. Herendeen joins Valeant from animal health company Zoetis (Florham Park, NJ), where he served as Executive Vice President and CFO for the past two years. Mr. Rosiello will remain at Valeant as Executive Vice President, Corporate Development and Strategy.